Related Experiment Video
Updated: Aug 5, 2026

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
Published on: January 10, 2025
Beyond biochemistry: multiparametric ultrasound parameters and their molecular correlates in cardio-renal-metabolic
Marcin L Kutek1,2,3, Jacek M Witkowski1
1Department of Embryology, Medical University of Gdańsk, Gdańsk, Poland.
Insights
Multiparametric ultrasound offers a non-invasive method to assess cardio-renal-metabolic syndrome (CRMS) by integrating multiple organ assessments. This approach shows promise for clinical use, pending further validation in prospective trials.
Area of Science:
- Cardiology
- Nephrology
- Metabolic Syndrome
- Medical Imaging
- Biomarkers
Background:
- Cardio-renal-metabolic syndrome (CRMS) involves visceral adiposity, insulin resistance, chronic kidney disease (CKD), and cardiovascular disease (CVD).
- Assessing the multi-organ burden of CRMS non-invasively at the point of care remains challenging.
- Established molecular markers often fail to capture the full spectrum of CRMS.
Purpose of the Study:
- To evaluate multiparametric ultrasound as an integrated imaging biomarker set for CRMS assessment.
- To determine if ultrasound can complement existing molecular markers for CRMS.
- To review evidence on ultrasound's utility in assessing components of CRMS.
Main Methods:
- Narrative literature search of PubMed (2015-2026) using PICO-structured queries.
- Analysis of studies correlating ultrasound parameters with metabolic, renal, and cardiovascular markers.
- Review of evidence on hepatic, epicardial, carotid, and renal ultrasound applications in CRMS.
Main Results:
- Hepatic ultrasound parameters correlate with insulin resistance and liver disease markers.
- Epicardial adipose tissue thickness is linked to inflammation and diastolic dysfunction.
- Carotid intima-media thickness and renal resistive index predict CKD progression and cardiovascular events.
- Renal shear wave elastography shows high accuracy in detecting kidney fibrosis.
Conclusions:
- Multiparametric ultrasound shows potential as a feasible, integrated biomarker for CRMS.
- Composite ultrasound-biochemistry models outperform single-parameter assessments.
- Further prospective trials are needed to validate specific ultrasound values against CRMS stages and establish multiorgan protocols.
Abstract:
Cardio-renal-metabolic syndrome (CRMS)-characterized by the pathological interplay of visceral adiposity, insulin resistance, chronic kidney disease, and cardiovascular disease-affects over 90% of US adults across its staging spectrum, yet its multi-organ burden remains difficult to assess non-invasively at the point of care. This narrative mini review examines whether multiparametric ultrasound within a single examination can serve as an integrated imaging biomarker set complementary to established molecular markers of CRMS. A narrative search of PubMed (2015-2026) was conducted using PICO-structured queries. The hepatic controlled attenuation parameter and liver stiffness measurement correlate directly with Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), CRP, and adipokine dysregulation, with pooled CAP cutoffs of 268-313 dB/m and elastography thresholds of 8.2-13.6 kPa for fibrosis staging in MASLD. Epicardial adipose tissue thickness correlates with circulating IL-17A (r = 0.308), hs-CRP (r = 0.666), and HOMA-IR (r = 0.567-0.580), independently predicting left ventricular diastolic dysfunction beyond BMI. Carotid intima-media thickness tracks eGFR decline longitudinally and predicts cardiovascular mortality in CKD populations. Renal resistive index, with a validated threshold of ≥0.70, independently predicts GFR decline and cardiovascular mortality across diabetic and hypertensive populations. Renal shear wave elastography distinguishes fibrotic from non-fibrotic parenchyma, with 93.1% sensitivity against biopsy. Cross-compartmental correlations and composite imaging-biochemistry models consistently outperform single-parameter approaches. Two critical gaps remain: specific ultrasound values have not been associated with AHA/ACC CKM stages, and no outcome study has validated a multiorgan protocol. Multiparametric ultrasound provides a clinically feasible, evidence-based CRMS assessment that remains to be validated in prospective trials.
Related Concept Videos
Imaging Studies II: Ultrasonography
Imaging Studies VII: Vascular Imaging
Dysrhythmias V: Evaluating Dysrhythmias
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System V: CT
